DIPAL PATEL: Open Payments
NPI 1841687548 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 71 payments from 17 companies in 2025. Trend: 2023 $113 · 2024 $730 · 2025 $1,693
Food & beverage: $1,693
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $314 |
| Inspire Medical Systems, Inc. | 2 | $224 |
| Amgen Inc. | 12 | $191 |
| AstraZeneca Pharmaceuticals LP | 8 | $189 |
| PFIZER INC. | 5 | $155 |
| Novo Nordisk Inc | 8 | $154 |
| ABBVIE INC. | 5 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Exact Sciences Corporation | 3 | $55 |
| Lilly USA, LLC | 3 | $46 |
Products named: Kerendia, INSPIRE, Ozempic, PREVNAR 20, FARXIGA, OTEZLA, LINZESS, EVENITY.
Industry payments across TX — which companies pay providers there.
